bioAffinity Technologies Inc

NAS:BIAFHealthcarenasdaq_composite

$3.51−5.90%At closeAt close · Tue 20 Oct · ≈ AED 12.89 · Market cap $4.5M · Next earnings Wed 18 Nov · Extended $3.53 +0.57%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	—	—	90.3%	31.3%	36.1%	23.2%	—	—
Operating margin	—	—	−83,511.5%	−314.9%	−95.6%	−171.6%	−171.6%	+0.0 pts
Net margin	—	—	−169,771.2%	−313.5%	−96.6%	−242.0%	−242.0%	+0.0 pts
EBITDA margin	—	—	−116,777.7%	−301.3%	−89.0%	−232.3%	—	—
Return on equity	48.2%	40.1%	−73.8%	−163.5%	−347.4%	−204.9%	−204.9%	+0.0 pts
Return on assets	−4,992.1%	−435.3%	−66.9%	−96.5%	−138.8%	−136.0%	−136.0%	+0.0 pts
Return on capital employed	23.7%	19.0%	−36.3%	−133.5%	−262.6%	−131.3%	—	—
Debt / equity	−0.7×	−0.7×	0.0×	0.3×	0.6×	0.2×	0.2×	+0.0%
Debt / assets	6,872.5%	782.0%	2.1%	19.2%	23.0%	10.6%	—	—
Interest coverage	−6.8×	−2.2×	−1.6×	−214.8×	−96.8×	−238.3×	—	—
Current ratio	0.0×	0.1×	10.5×	1.8×	0.9×	2.6×	2.6×	+0.0%
Quick ratio	0.0×	0.1×	10.5×	1.8×	0.9×	2.6×	—	—
Cash ratio	0.0×	0.1×	10.0×	1.3×	0.4×	2.2×	2.2×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.3×	1.4×	0.6×	—	—
Inventory turnover	0.8×	—	0.1×	94.2×	216.7×	88.4×	—	—
Receivables turnover	0.0×	0.0×	0.5×	3.1×	8.2×	11.4×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—